Sophia Genetics SA (STU:90B)

Q1 2025 Sophia Genetics SA Earnings Call Transcript

May 06, 2025 / 12:00PM GMT

Release Date Price: €2.62

Transcript

Key Points

Positve

Sophia Genetics SA (SOPH) reported a 15% revenue growth on a constant currency basis, exceeding expectations.
The company successfully implemented 33 new customers in Q1 2025, up from an average of 23 per quarter in 2024.
Sophia Genetics SA (SOPH) achieved a record 75.7% adjusted gross margin, up 520 basis points year over year.
The company expanded its partnership with AstraZeneca to deploy MSK-ACCESS globally, highlighting strong biopharma interest.
Sophia Genetics SA (SOPH) reduced its adjusted EBITDA loss by 24% year over year, demonstrating improved cost management.

Negative

Biopharma continues to present modest headwinds, impacting overall growth.
Latin America experienced a slight decline due to the acquisition of a top customer by another lab.
The company churned out a few smaller accounts that had not generated revenue over the past 12 months.
Despite strong Q1 results, the company maintains a back-half weighted revenue guidance for 2025.
Gross margins in Q1 were higher than expected due to favorable mix, which may not be sustainable in future quarters.

Operator

Good morning ladies and gentlemen and welcome to the Sophia Genetics Q1 2025 earnings call. At this time, online journal listen-only mode. (Operator Instructions)

This call is being recorded on Tuesday, May 6, 2025. I would now like to turn the conference over to Kelly Sanger to be a genetics Head of the Strategy and Investor Relations. Please go ahead.

Kellen Sanger;Strategy;Investor Relations

Sophia Genetics SA - Head

:&

Thank you and good morning, everyone. Welcome to the Sophia Genetics first quarter of 2025 earnings conference call. Joining me today to discuss the results are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; Ross Muken, our company President; and George Cardoso, our Chief Financial Officer. I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.